Topics

Latest "opportunity dignity safety Experts emphasize multiple gaps facing" News Stories

13:47 EDT 14th October 2019 | BioPortfolio

Here are the most relevant search results for "opportunity dignity safety Experts emphasize multiple gaps facing" found in our extensive news archives from over 250 global news sources.

More Information about opportunity dignity safety Experts emphasize multiple gaps facing on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about opportunity dignity safety Experts emphasize multiple gaps facing for you to read. Along with our medical data and news we also list opportunity dignity safety Experts emphasize multiple gaps facing Clinical Trials, which are updated daily. BioPortfolio also has a large database of opportunity dignity safety Experts emphasize multiple gaps facing Companies for you to search.

Showing "opportunity dignity safety Experts emphasize multiple gaps facing" News Articles 1–25 of 15,000+

Monday 14th October 2019

Vaping: UK experts defend safety in face of US lung injury cases

The outbreak of lung injuries in the US among people using electronic cigarettes should not deter UK smokers from using them, a panel of experts told a briefing at the Science Media Centre in London....


How to ensure your safety when working alone

Pharmacy professionals give their thoughts and advice to a locum pharmacist required to work alone at night.

Global Biologics Safety Testing Market Size Study, By Product Instruments, Services, Kits Reagents, By Test Endotoxin, Sterility Test, Cell Line Authentication, Bioburden, Others, By Application Vaccine Therapeutics Development, Blood Products Testing,

Global Biologics Safety Testing industry valued approximately USD 2.41 billion in 2016 is anticipated to grow with a healthy growth rate of more than 13.38% over the forecast period 20172025. The factors speculated to propel the market are the surge in number launches of new drugs, and the development in biotechnology pharmaceutical industry owing to the government encouragement in these industri...


Coda Signature Now Available in Over 100 California Dispensaries

Products on the shelves at leading retail outlets including MedMen Coda Signature, maker of award-winning cannabis infused gourmet edibles, all-natural topicals and handcrafted concentrates, announces massive growth in distribution throughout the state of California. In only two months, the brand can be found at more than 100 dispensaries, including top retailers

Netsmart Delivering Hands-on Training to Home Health Agencies in Anticipation of PDGM

Netsmart announced today that it is on track to meet technology development milestones to accommodate new regulatory requirements as directed by the Patient-Driven Groupings Model (PDGM). The

The Rite Aid Foundation Awards $2.3 Million to Children’s Miracle Network Hospitals

 20 Local Children’s Hospitals Receive Grants to Improve the Health and Wellbeing of Children in Their Communities The Rite Aid Foundation announced today that it’s awarding $2.3 million to Children’s Miracle Network Hospitals across the nation through a special KidCents Grant Program. The grants will enable local children’s hospitals to advance initiatives focused on improving the heal...

STA To Market Sarcoma Drug In Australia, New Zealand And SE Asia Following License Deal

Key Highlights: -- YONDELIS® (trabectedin) is a globally recognised treatment for patients with advanced soft tissue sarcoma as second-line therapy and beyond, but has been difficult for Australians to access -- YONDELIS demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 -- Specialised Ther...

Myeloma Regimens Require Coping Mechanisms for Toxicity

Adam J. Waxman, MD, MS, discusses new and upcoming multiple myeloma treatments and how to optimally manage toxicities from these regimens. 

RMS Medical Products to Commence Trading on NASDAQ

Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical” or “the Company”) today announced that its common stock has been approved for listing and is expected to begin trading on the NASDAQ Capital Market on October 17, 2019 under the current symbol “REPR”. The Company’s common stock will continue to trade on the OTCQX until market close on October 16, 2019. "...

Managed Cyber Security Services Market Size study, by Application Risk Compliance Management, Identity Access Management, Managed Security Device Management, Vulnerability Management, Others, by End User Discrete Manufacturing, Government Agencies, BFSI

Managed Cyber Security Services Market to reach USD 55.0 billion by 2025.Managed Cyber Security Services Market valued approximately USD 17.234 billion in 2017 is anticipated to grow with a healthy growth rate of more than 15.62% over the forecast period 20182025. The process of safeguarding data and information from the threats on the internet is known as cyber security. Cybersecurity strategies ...

Biorelate launches AI-powered curation engine, Galactic, to combat the growing challenge of information overload in biomedicine.

Early adopters include McCann Health Medical Communications, ApconiX and the UK’s Cell & Gene Therapy Catapult Manchester, UK & San Diego, CA, 10 October 2019 – Biorelate, the AI company curating biomedical knowledge, today announces the launch of its proprietary tool for accelerated research intelligence, Galactic, at BioData World West 2019. The digitisation of informat...

MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Study 14.10.2019 / 13:01 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, and Shanghai, China, October 14, 2019 MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China   MorphoSys AG (FSE...

Get vaccinated to protect yourself from flu, say Johns Hopkins experts

Cases of the flu are already on the rise around the nation as flu season begins. Johns Hopkins Medicine experts say now is the time to fight against the flu as the number of people getting sick from the potentially life-threatening virus will increase in the coming months.

Global Wind Turbine Pitch Systems Market Size study, by Type Hydraulic Pitch Systems, Electrical Pitch Systems, by Application Offshore, Onshore and Regional Forecasts 20182025 [Report Updated: 01042019] Prices from USD $3950

Global Wind Turbine Pitch Systems Market valued approximately USD 1.53 billion in 2017 is anticipated to grow with a healthy growth rate of more than 2.14% over the forecast period 20182025. The Wind Turbine Pitch Systems Market is continuously growing in the global scenario at significant pace. Pitch control is the technology used to operate and control the angle of the blades in a wind turbine....

Savonix Names Jillian Kwan-Jacobs New Chief Operating Officer

Savonix, a global leader in digital tests for cognitive health, today announced the appointment of Jillian Kwan-Jacobs as Chief Operating Officer effective October 18, 2019. She will be a key member of the executive management team, reporting directly to Dr. Mylea Charvat, CEO & Founder, Savonix. As COO, Kwan-Jacobs will be responsible for strategic oversight for Finance, Global and US Oper...

Rituxan hits targets in late-stage pemphigus vulgaris trial

The study is still ongoing, with patients participating in a 48-week safety follow-up period.

Hyperfine and Yale School of Medicine Collaborate on World’s First Portable MRI Technology

Hyperfine Research Inc. announced today its collaboration with the Yale School of Medicine to pioneer the use of the world’s first portable, low-cost magnetic resonance imaging (MRI) system at the bedside of patients in the neuro intensive care unit of Yale New Haven Hospital. Hyperfine’s system can move directly to the bedside, plug into a wall outlet, and operate in any healthcare setting. ...

Ferring Pharmaceuticals to Present New Fertility Data at ASRM 2019 Scientific Congress & Expo

Ferring will deliver two oral presentations; one showcasing data from MEGASET-HR and the other discussing the influence of body weight on ovarian response in women undergoing stimulation as part of an in vitro fertilization (IVF) cycle The company will also be sharing three poster presentations; one analyzing fertility treatment cost, one exploring access to fertility treatment and another pre...

Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne

- Mark Foley to lead company as it gears up to commercialize next-generation neuromodulator – - Change in leadership unrelated to company performance - - Revance on track to submit BLA for DAXI for the treatment of glabellar lines in the Fall of 2019, as previously announced - Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulators f...

Netsmart Post-Acute Experts and Clients to Share Insight, Expertise at AHCA/NCAL Convention and Expo

  Netsmart announced today that several clients and Netsmart post-acute leaders will be presenting at the American Health Care Association/National Center for Assisted Living (AHCA/NCAL) 2019 Convention and Expo on hot topics that include assu

Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology

Data from pivotal study demonstrate safety and efficacy regardless of prior gastrectomy in previously treated patients with metastatic gastric cancer (mGC) and gastroesophageal junction (GEJ) adenocarcinoma Servier and its partner Taiho Oncology, Inc. (US), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), announced today that detailed results from the analysis of patients with prior gastr...

Chronically ill prisoners risk of being transferred without medication because of gaps in care

Around 120 prisoners with chronic conditions are moved between prisons every day in England, but gaps in care mean many are at risk of going without their medication, says a report.1The report by the...

DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease

DiaMedica Therapeutics Inc. (Nasdaq: DMAC) announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Phase II clinical trial protocol for the treatment of Chronic Kidney Disease (CKD). The Phase II trial is designed to assess the safety and efficacy of DM199 in the treatment of CKD in two cohorts: patients with CKD caused by IgA nephropathy (IgAN) and hypertens...

Apyx Medical Corporation Announces Subject Enrollment Initiated in Study Evaluating the Use of Renuvion® Technology in Skin Laxity Procedures in the Neck and Submental Region

Apyx Medical Corporation, formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and as J-Plasma® in the hospital surgical market, announced today that it has initiated subject enrollment in an FDA approved U.S. Investigational ...

Global Mobile Phone Insurance Ecosystem Market Size study, by Type Wireless Carrier, Insurance Specialists, Device OEMs, Retailers, by Application Physical Damage, Theft Loss, Others and Regional Forecasts 20182025 [Report Updated: 01042019] Prices from

Global Mobile Phone Insurance Ecosystem Market valued approximately USD 18.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 9.32% over the forecast period 20182025. The Mobile Phone Insurance Ecosystem Market is continuously growing in the global scenario at significant pace. Mobile insurance refers to a type of insurance cover which is available to protect your mob...


Quick Search

News Quicklinks